In the News with GMI
In the News
The Importance of Early Diagnosis in Alzheimer’s and Memory Loss: How Clinical Trials Are Helping
Alzheimer’s disease and other forms of memory loss affect millions of people worldwide, impacting not only those diagnosed but also their families and caregivers. Early
Understanding the Role of Clinical Trials in PTSD Treatment and Recovery
Post-Traumatic Stress Disorder (PTSD) affects millions of people worldwide, often disrupting their daily lives, relationships, and overall sense of well-being. While traditional treatments such as
How Clinical Trials Are Advancing Treatments for ADHD
Attention-Deficit/Hyperactivity Disorder (ADHD) affects millions of children and adults worldwide, influencing focus, behavior, and daily functioning. While traditional medications and behavioral therapies have helped many
What’s Next for Alzheimer’s and Dementia Research in 2026?
Alzheimer’s and dementia continue to be some of the most pressing health challenges worldwide. As research advances, 2026 is shaping up to be a year
Alzheimer’s Disease: How Clinical Trials Are Helping Patients Maintain Cognitive Function
Alzheimer’s disease is a progressive neurological disorder that impacts memory, thinking, and behavior, often making daily life increasingly difficult. While there is currently no cure,
New Approaches to Treating ADHD Through Clinical Research
Attention Deficit Hyperactivity Disorder (ADHD) affects millions worldwide, impacting focus, impulse control, and daily functioning. While traditional treatments have helped many, ongoing clinical research is
